• Inside Government – July 24th, 2009

    Phil Glover AFGE Council of Prison Locals Legislative Coordinator

    Terry Rosen AFGE Labor Relations Specialist

    Perry Hooks President, Hooks Book Events

    Jeff Goldman Executive Director of Government Programs, Kaiser Permanente

  • Inside Government – August 7th, 2009

    Michael D. Yates Author of ”Why Unions Matter”

    Elise Gould Director of Health Policy Research, Economic Policy Institute

    Tom Webb President, AFGE SSA Local 3615

  • National Institute of Allergies and Infectious Diseases

    Anthony Fauci Director National Institute of Allergies and Infectious Diseases

    September 21st and September 23rd

  • ICD-10: Risk Or Opportunity?

    The new mandated International Classification of Diseases, 10th edition (ICD-10) must be implemented by October 1, 2013. ICD-10—a complete replacement of the ICD-9 code sets used to report healthcare diagnoses and procedures—will affect all segments of the healthcare industry, including providers, clearinghouses and health plans, as well as government agencies.

    ICD-10, however, is more than an IT effort. It is a regulation that has a large impact on policies, business operations, clinical processes, and healthcare outcomes research. Preparing for ICD-10 will require an organization-wide approach and an understanding of all the areas impacted by its adoption.

    Noblis—a nonprofit science, technology and strategy organization with a proven record of success working on ICD-10—is pleased to facilitate a panel discussion to exchange information and ideas among key public and private sector stakeholders. Together, the panel experts will discuss the risks and opportunities of the ICD-10 transition, what their organizations are doing now to get started, and where ICD-10 fits compared to other large initiatives.

  • NIH Research Identifies At Risk Infants

    A study funded by the National Institutes of Health – using an electro-encephalogram, a machine that records the brain’s electrical activity – shows newborn infants are capable of a simple form of learning while they’re asleep. The finding may one day lead to a test that can identify infants at risk for developmental disorders.

    The NIH National Institute of Child Health and Human Development sponsors research on development, before and after birth.

    The machine measured the babies brain’s electrical activity while a video camera recorded each baby’s facial expressions, as researchers played a tone, as a machine blew a puff of air at each sleeping infant’s eyelids. The electroencephalogram detected changes in brain wave activity that occurred simultaneously with the tone, showing the infants had learned to associate the tone with the puff of air.

  • Turning A Painkiller Into A Cancer Killer

    Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer.

    Now, in a study appearing in Cancer Cell magazine, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one such drug, called Sulindac, inhibits the growth of tumors. The study reveals that the drug shuts down cancer cell growth, and initiates the death of cells by binding to a nuclear receptor, that can then turn genes on or off.

    Sulindac is currently prescribed for the treatment of pain and fever, and to help relieve symptoms of arthritis. The current study demonstrates a new application as a potential anti-cancer treatment that targets certain kinds of tumors.

  • Groundbreaking Joint Regenerative Procedure Tests Well

    Using a cutting edge process to form new joints inside the body, a team of researchers funded by the National Institutes of Health has successfully regenerated rabbit joints. The experiment demonstrates that it’s possible to grow dissimilar tissues, like cartilage and bone, taken entirely from the host’s own cells.

    The regenerative procedure is performed by stimulating previously irreparable organs or tissues to heal themselves. Three-dimensional structures made of biocompatible and biodegradable materials in the shape of the tissue, are infused with a protein to promote the joint’s growth.

    The approach sidesteps several problems that are typically encountered in trying to transplant cells that are grown externally, such as tissue rejection.

    Future work could replace arthritic joints in animals and ultimately in arthritis patients who need total joint replacement.

  • How to tune out noise in your office

    Patrick Skerrett of Harvard Health Letter offers tips for tuning out noisy distractions in your office.

  • D.C. VA Medical Center hosts ‘Ladies’ Night’

    The Washington D.C. VA Medical Center is hosting an evening of music, pampering and health information just for female veterans. We get details from the VA’s Diane Phillips

  • Federal health claims database delayed by OPM

    A huge change to the FEHBP did not come off as planned. OPM’s planned Health Claims Data Warehouse was supposed to launch yesterday. Instead, a notice has appeared in the Federal Register extending the comment…